Bortezomib Biotech Pharma 3.5 mg powder for solution for injection

Licence status
Authorised: 26/06/2020
Active substances
Bortezomib
Dosage Form
Powder for solution for injection
Licence number
PA25233/001/001
Licence holder
Target Healthcare Limited

Product documents

Licence information

ATC code
L01XX32 bortezomib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/06/2020